
ZavzpretTM nasal spray for migraine gets FDA approval
ZavzpretTM (zavegepant) nasal spray, a calcitonin gene-related peptide (CGRP) receptor antagonist, has been authorised by the Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults.